Cellular Analysis Services for Brain Tumors

Brain tumor stem cells (BTSCs) have multiple differentiation potentials and can be induced to differentiate into a variety of terminally differentiated cells. We can isolate brain tumor cells from brain tumor tissue specimens and obtain BTSCs after a period of culture in a serum-free medium. we can identify and analyze the biological properties of BTSCs. Our isolated BTSCs can be passaged, lyophilized, and revived, and with high quality, they can meet your different research needs and provide reliable information for your further brain tumor research.

As an important marker in liquid biopsy technology, CTCs can reflect the more complete biological information of brain tumors. We offer clients a variety of methods based on CTCs detection in brain tumors. In addition, we also provide single-cell sequencing services for CTCs in brain tumors. We can identify individual CTCs or CTM oncogenes and oncogenes, and analyze brain tumor survival factors. This is very critical for real-time monitoring of brain tumor dynamics, assessing treatment efficacy, and personalizing treatment.

We have built cell microarrays based on microfluidic principles that integrate cell screening/capture, culture, and cell functional analysis. We can use biologically active small molecule peptides to bio-functional modify microchannels on a simple cross-shaped microfluidic chip. We build a functionalized microenvironment with strong peptide binding, orderly arrangement, and uniform distribution to improve the sensitivity, specificity, and biocompatibility of the microchip system.

Finding brain tumor-critical cell populations and tracing the cells of origin can advance current researchers' insights into the mechanisms of brain tumorigenesis. We offer researchers in the field of brain tumor research by providing assay analysis services for BTICs, EVs, and many other types of rare brain tumor cells from which to obtain additional information about brain tumors. We can assist you in the optimization of brain tumor treatment protocols, biomarker discovery, and new target development.

We combine statistical correction methods and image analysis techniques to determine the DNA content of brain tumor cells and the distribution of DNA ploidy cells. In addition to the traditional statistical analysis method, we have improved the method. This can effectively eliminate the influence of external factors on DNA content determination and improve the accuracy and objectivity of DNA content values, thus improving the accuracy of brain tumor diagnosis.